Ondas Inc. (ONDS) delivered another blowout top line in the third quarter. Revenue roughly doubled sequentially to $167.49 million, up from $83.8 million in Q2. It topped the $147.05 million consensus by 13.9% and cleared management's own $140-155 million guide. Year over year, revenue grew 1558.6%, largely because of an aggressive acquisition program. The bottom line is murkier. Ondas reported a loss of $0.10 per share, a penny wider than the -$0.09 consensus but narrower than the -$0.13 Earnings Whisper number, for a 23.1% beat against that whisper. Earnings fell 66.7% from the year-ago loss of $0.03. That is the central tension: revenue is scaling faster than almost anyone modeled, while profitability per dollar of revenue moved sharply in the wrong direction.

The quality of the earnings line deserves scrutiny. The GAAP net loss of $64.7 million was cushioned by $125.1 million of non-cash gains from remeasuring warrants. Without that gain, the operating loss of $189.5 million would have dominated. That figure includes $57.8 million of stock-based compensation and $25.3 million of operating amortization. The more telling deterioration came in the gross line. GAAP gross margin fell to 21.8% from 43.1% in Q2, and gross profit was essentially flat at $36.5 million despite twice the revenue. Even on an adjusted basis, gross margin dropped to 34.8% from 50.4%. Management attributed the decline to production and delivery inefficiencies in precision strike, the low-margin Lethal Unmanned Strike (LUS) work that made up a disproportionate share of revenue. Adjusted EBITDA loss widened to $59.7 million. The release puts the Q2 loss at $46.2 million, while the call framed it at roughly $51 million. Either way, the loss grew, which undercuts management's earlier suggestion that Q2 would mark the peak loss. Adjusted EBITDA definitions were also broadened again this quarter to exclude inventory step-ups and acquisition-related employee and integration costs.

The call preserved a credible growth story. Even so, several underlying metrics decelerated. Pro forma organic growth slowed to 64% from 85% in Q2, though management guided Q4 organic growth back to at least 75%. ISR backlog was flat sequentially. Margin expectations were also cut. Management expects mid-30s adjusted gross margin again in Q4. The long-term target is now 45-50% over 12 to 24 months, down from above 50% on the Q2 call and a 50-60% aspiration earlier in the year. Adjusted cash operating expenses climbed to $118.7 million, and R&D jumped $30 million sequentially to $61.6 million. Management nonetheless insists growth opex is moderating.

The forward catalysts explain why the company is leaning in:

• **Revenue guidance:** The full-year 2026 target rose to at least $550 million, and Q4 is guided above $250 million. That target has been raised on every call this year, starting from $375 million.
• **2027 outlook:** A first 2027 target of at least $1.1 billion assumes more than 40% organic growth and excludes M&A.
• **Profitability timeline:** Company-wide adjusted EBITDA breakeven moved up to Q3 2027 from Q4 2027, the second time it has been pulled forward. Operating-platform breakeven is still expected in Q4 2026.
• **Orders and programs:** Backlog rose to $835 million on $214 million of bookings. Key drivers include ULTRA follow-ons, a pending Stemme airframe acquisition, IonStrike production targeted at thousands of units per month from late 2027, and volume deliveries starting on a $140 million combat engineering vehicle program.
• **Optionality outside guidance:** The new Regna AI sovereign-AI venture, built with NVIDIA and Palantir technology, is not in guidance.

Bears have legitimate ammunition. Cash, restricted cash, and short-term investments fell to about $820 million from roughly $1.4 billion after about $431 million of acquisitions. Inventory nearly doubled, capex is set to rise, and management acknowledged that non-dilutive financing may be needed for the production ramp. Shares outstanding rose to about 590 million from 381 million at year-end, and the warrant liability stands at $918.6 million. Program ramp execution and U.S. budget uncertainty also remain live risks.

The market setup is more complicated than the surprise implies. Investor sentiment collapsed from a solidly positive 0.45 after the prior report to essentially neutral at -0.001. Entering the report, the stock had fallen 36.2% since the open following the August release. It sat 34.7% below its 200-day moving average and about 41% beneath the inter-earnings high of $9.64 set the day after that report. Shares hit a 52-week low of $4.38 on November 5 and had rebounded 31% from that level heading into the print. The Earnings Whispers trend readings are mixed: sequential growth and momentum are positive, while price and AVWAP trends remain negative. That split mirrors the divide between improving revenue and a deteriorating chart.

The bottom line is that Ondas is executing on volume but not yet on economics. Revenue, backlog, and guidance all moved higher. Margins, the adjusted EBITDA loss, organic growth, and the cash balance moved the other way, and the long-term margin ambition was trimmed. The earlier breakeven target and the $1.1 billion 2027 outlook give bulls something concrete. Still, a stock that has already shed more than a third of its value since August needs evidence that the Q3 margin dip is the temporary ramp effect management describes, and not the new cost of scale.